(HealthDay)—Venetoclax (VENCLEXTA) has been approved to treat adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma, the U.S. Food and Drug Administration announced yesterday.
May 17, 2019
0
1
Researchers at the Burrell College of Osteopathic Medicine (BCOM) have found that cancer patients in New Mexico have lower chances of survival when compared to the rest of the nation.
May 13, 2019
0
3
Researchers from Queen Mary University of London studied the effectiveness of one of the largest ever national quality improvement programmes in the National Health Service (NHS) and found no improvement in patient survival.
Apr 26, 2019
0
17
Scientists have identified key changes in immune cells within cancerous tumours that could help improve the development of treatments.
Apr 8, 2019
0
79
According to a new study, breast cancer patients who don't respond to targeted therapy have different patterns of epigenetic modifications than patients who do respond. Epigenetic modifications change gene expression without ...
Apr 7, 2019
0
5
Glioblastoma is the most aggressive type of primary brain cancer, one with a prognosis of 11-15 months with standard treatment. Results from a phase 1b clinical trial of a new experimental glioblastoma vaccine developed by ...
Mar 31, 2019
0
16
By any measure, lung cancer patients have it rough.
Mar 21, 2019
0
0
(HealthDay)—The U.S. Food and Drug Administration has given its blessing to the first immunotherapy regimen for breast cancer.
Mar 12, 2019
0
54
Pancreatic cancer is the third most lethal cancer in the United States. Patients typically don't know they have it until it's too late, making it difficult to treat. Only 9 percent survive five years after diagnosis.
Feb 6, 2019
0
1
It's one of the first questions asked by many newly-diagnosed cancer patients—"What are my chances of beating this?" Often there is no clear answer, with survival rates differing widely depending on the cancer stage and ...
Jan 10, 2019
0
2
